The latest news from PTC

PTC UK was the first office to open in Europe and hire the first employees to serve our patients in the region. Today, 23 employees are based in the UK, leading regional and global functions. In the last 10 years, the PTC UK team have worked in partnership with the scientific and rare disease community…

At PTC, we invest in our people and dedicate resources to development and learning, ensuring our employees are supported and empowered in their careers. Investing in our employees’ learning, skills and career development is integral to PTC’s success. We offer several resources to support our employees’ well‑being, learning and career development while providing growth opportunities.…

In honor of International PKU Awareness Day, June 28, members of the community helped us to debunk common myths about PKU. Watch the video below to hear from PKU advocates, healthcare professionals, a person living with PKU and a caregiver as they share the facts: International PKU Awareness Day is a global day hosted by…

Since 2014, the PTC office in Ireland has been the company’s international headquarters and a regional hub. With nine departments and more than 50 employees*, the cross-functional teams facilitate supply of PTC’s medicines across 50+ geographies, manage global quality operations and global pharmacovigilance activities as well as commercial sales and finances for Europe, Middle East…

It has been 10 years since PTC entered the European market with a mission to improve the lives of people living with rare diseases.  In the past decade, we have pioneered transformative progress and created possibilities for the rare disease community across Europe. PTC was founded with the mission to leverage its novel drug discovery…

Clinical trials provide the medical community with valuable research and data that helps to facilitate the development of new and potentially life-saving therapies. By participating in a clinical trial, you are taking an active role in the development and approval of new medicines and treatments. There is a lot to learn about clinical trials –…

An Informative Q&A with Jonathan Cherry, Global Project Leader Our research efforts at PTC are focused on two scientific platforms – splicing and ferroptosis and inflammation – where PTC has unique expertise to discover and advance innovative therapies to the clinic. We recently sat down with Jonathan Cherry, Global Project Leader, to learn more about…

In honor of Huntington’s disease (HD) Awareness Month, we are highlighting inspiring and impactful voices from the HD community. Watch the video below to learn more about this rare, hereditary, genetic disorder of the central nervous system, and hear from the global community about their hope for the future of HD.

We are excited to announce that PTC has been named a winner of the 2024 Don Clifton Strengths-Based Culture Award from Gallup. This is the third time PTC has won this award that recognizes organizations with strong workplace cultures that get the best out of their employees by developing their strengths and placing them at…

At PTC, we strive to be good citizens of the world and make change for a better planet, because as a science-based company, we understand the impact people have on the environment. We pride ourselves not only on our innovative work but on our commitment to sustainability and social responsibility. To bring this mission to…